How dietary fructose affects fat tissue function and metabolism
Exploring the mechanisms by which dietary fructose primarily impairs white adipose, not hepatic, function: insights from a novel ketohexokinase antisense oligonucleotide
This study is looking at how eating moderate amounts of fructose affects fat tissue and insulin sensitivity, which is important for people with type 2 diabetes and heart disease, by using special techniques in animal models to see how different levels of fructose in the diet can impact overall health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | VA Connecticut Healthcare System NIH-funded |
| Lab location | 1 site (West Haven, United States) |
| Project ID | NIH-10951536 on NIH RePORTER |
What this research studies
This research investigates how moderate consumption of dietary fructose impacts the function of fat tissue, particularly in relation to insulin sensitivity and metabolism. By using a novel antisense oligonucleotide to inhibit the enzyme ketohexokinase (KHK), the study aims to understand the mechanisms behind fructose metabolism and its effects on adipose tissue. The research involves animal models to explore how different diets with varying fructose levels influence metabolic health, particularly in conditions like type 2 diabetes and cardiovascular disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with metabolic disorders such as type 2 diabetes or those at risk due to high fructose consumption.
Not a fit: Patients who do not consume fructose or have no metabolic disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve metabolic health and insulin sensitivity in patients consuming fructose.
How similar studies have performed: Other research has shown promising results in understanding fructose metabolism and its implications for metabolic health, suggesting that this approach could yield valuable insights.
Where this research is happening
West Haven, United States
- VA Connecticut Healthcare System — West Haven, United States (Active)
Researchers
- Principal investigator: Samuel, Varman T — VA Connecticut Healthcare System
- Study coordinator: Samuel, Varman T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.